Gut mycobiome

The term "**gut fungal population**" refers collectively to the fungi residing in the human gastrointestinal (GI) tract, which together constitute the **gut mycobiome**[3][5]. This community is a small subset of the gut microbiota, predominantly composed of members of the phyla *Ascomycota* and *Basidiomycota*, with genera such as *Saccharomyces*, *Candida*, *Aspergillus*, and *Malassezia* being among the most frequently detected[2][4][5]. Fungal diversity in the gut is much lower than that of bacteria, both in terms of taxa and gene content, but can vary substantially between individuals and over time within the same host[4][3][5].\n\nThe gut mycobiome interacts with the host and other microbes in complex ways, influencing immune responses, maintaining ecological balance with bacterial microbiota, and potentially affecting disease states such as inflammation and infections[2][3][5]. The majority of the fungi may be transient, derived from diet or the environment, rather than being consistent resident colonizers[3][6]. Methodological problems, inter-individual variability, and the low abundance of fungi limit the development of a consensus “healthy” gut mycobiome[4][6].\n\nThere are currently no known drugs, mechanisms of action, or biomarkers that specifically target or use the "gut fungal population" as a single therapeutic target. Instead, when specific fungi (e.g., *Candida albicans*) are clinically relevant, targeted antifungal therapies may be used, but these do not target the entire gut fungal community[3][5]. Thus, while the gut mycobiome is implicated in modulating health and disease, it is not itself a conventional drug target (such as a receptor or enzyme), but rather a descriptive collective term for all gut fungi[3][4].\n\n**Key caveat:** \n"Gut fungal population" is not a single, discrete molecule, protein, receptor, or gene that can serve as a direct therapeutic target. It is a complex and variable ecosystem collectively referred to as the **gut mycobiome**. Any attempt to use this as a pharmacological target must instead focus on specific fungal species or functions within this ecological context[5][6].

Other names

Gut fungal communityIntestinal mycobiomeFungi of the gutFungal gut microbiotaFungal population of the gastrointestinal tract